PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26485709-11 2015 According to the results, trabectedin induced cytotoxicity and apoptosis at the IC50 dose, resulting in a significant increase expression of caspase-3, caspase-8, caspase-9, p53 and decrease expression of bcl-2 in dose-dependent manner. Trabectedin 26-37 tumor protein p53 Homo sapiens 174-177 16888811-0 2007 Extreme sensitivity to Yondelis (Trabectedin, ET-743) in low passaged sarcoma cell lines correlates with mutated p53. Trabectedin 46-52 tumor protein p53 Homo sapiens 113-116 11205907-9 2001 By contrast with camptothecin, these lesions persisted for several hours after drug removal and were not formed at 4 degrees C. Et743 treatment induced transient p53 elevation, dose-dependent cell cycle accumulation in G2-M and in G1- and S-phase, and inhibition of DNA synthesis. Trabectedin 128-133 tumor protein p53 Homo sapiens 162-165 16533604-3 2006 ET-743, a DNA minor groove binder, which blocks cell cycle progression in G2/M phase through a p53-independent apoptotic process, represents the most promising among novel compounds in STS, since recently completed phase II trials have consistently shown high survival, in spite of the relatively low incidence of major objective responses. Trabectedin 0-6 tumor protein p53 Homo sapiens 95-98 18393778-7 2006 Finally, another new drug, ecteinascidin (ET-743), that blocks cell cycle progression in G2/M phase through a p53-independent apoptotic mechanism, has shown important preclinical and clinical activity against a number of human solid tumors, including GIST. Trabectedin 27-40 tumor protein p53 Homo sapiens 110-113 18393778-7 2006 Finally, another new drug, ecteinascidin (ET-743), that blocks cell cycle progression in G2/M phase through a p53-independent apoptotic mechanism, has shown important preclinical and clinical activity against a number of human solid tumors, including GIST. Trabectedin 42-48 tumor protein p53 Homo sapiens 110-113 11165136-5 2001 ET-743 induced a significant increase in p53 levels in cell lines expressing wild-type (wt) (p53). Trabectedin 0-6 tumor protein p53 Homo sapiens 41-44 11165136-5 2001 ET-743 induced a significant increase in p53 levels in cell lines expressing wild-type (wt) (p53). Trabectedin 0-6 tumor protein p53 Homo sapiens 93-96